| | | | | | | Article 5 Pioneering the future of human health through biosolutions | | | | | Novozymes and Chr. Hansen have officially merged to form Novonesis, marking the largest merger in Danish history. This powerful collaboration combines over a century of innovation and expertise, positioning Novonesis as a global leader dedicated to tackling some of humanity's most pressing challenges through biological solutions.
A highlight of this merger is the formation of the Novonesis human health division, which stands out in the biosolutions landscape with its unique Strain to Solution™ approach. This capability allows Novonesis to partner with customers from the initial stages of product ideation all the way to shelf-ready products.
This merger will not only enhance Novonesis' capabilities but also expand it's impact on global health and well-being. Read more inside! | | Read more | | | | In order to view this asset, you must first log in to your SupplySide Supplement Journal account. Don't have an account? Join the community by signing up here! | | | | Paid content: | | | | | | |
|
|
|
|
